Why is the FDA looking into the safety of Botox?
A Washington, D.C.-based consumer watchdog group called Public Citizen reviewed FDA data and found that the agency had received reports of 180 U.S. cases of people developing sometimes life-threatening conditions, including respiratory failure, after receiving Botox injections (botulinum Types A and B). Sixteen deaths had occurred, four of which were of children less than 18 years old. Public Citizen then filed a petition with the FDA calling for stronger and more widely disseminated warnings concerning these risks.
